MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced the closing of its previously announced $100 million private investment in public equity (PIPE) financing. This substantial investment reinforces the Company's financial position and propels its late-stage non-opioid therapeutic programs toward key clinical and regulatory milestones. The financing also facilitates the integration of MindWave Innovations Inc., aligning corporate operations and. ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As Bitcoin’s shine dulls and market saturation squeezes returns, a new breed of publicly traded crypto treasury companies is making a risky pivot that has analysts sounding alarm bells about heightened volatility ahead. The trend marks a dramatic shift for digital asset treasury companies, which exploded in popularity following the meteoric success of Strategy (NASDAQ:MSTR) and its founder, Michael Saylor. ...

LOS ANGELES--(BUSINESS WIRE)---- $CGEH #AIInfrastructure--Capstone Green Energy Holdings, Inc. (the "Company†or "Capstone†) (OTCQX: CGEH), together with its subsidiaries, a leading provider of clean technology solutions using ultra-low-emission microturbine energy systems, today announced the closing of its previously announced private investment in public equity financing (the "PIPE†), resulting in gross proceeds of approximately $15 million (before fees and expenses). The Company issued an aggregate o ...

Core Insights - Solmate Infrastructure, backed by Cathie Wood, experienced a nearly 50% increase in shares following the announcement of an aggressive mergers and acquisitions strategy and additional Solana (SOL) purchases at discounted prices [1] - The company has completed its first validator hardware assembly in the UAE, aiming to launch the region's first performant Solana validator [1] - Solmate's recent acquisition of SOL tokens at a 15% discount during a significant liquidation event in the crypto market supports its validator operations [2] Company Developments - Solmate's stock reached an intraday high of $12.55, settling at $11.70, resulting in a market capitalization of approximately $754 million [2] - The company is focusing on strategic acquisitions across the Solana value chain rather than merely revenue-driven deals, as stated by CEO Marco Santori [3] - Santori emphasized that the company is not interested in acquiring smaller companies but rather targeting businesses that can leverage its SOL treasury for growth [4] Financial Activities - Solmate announced an amendment to its registration rights agreement for its oversubscribed $300 million private investment in public equity (PIPE) financing [4] - The registration statement for PIPE investors is expected to be filed with the U.S. Securities and Exchange Commission by November 22 [5] - The $300 million financing round, completed in September, received backing from notable investors including ARK Invest and the Solana Foundation [5]

Core Points - Safe and Green Development Corporation (SGD) has entered into a securities purchase agreement for a PIPE financing, raising approximately $9.0 million before fees and expenses [1][2][3] Group 1: PIPE Financing Details - The company is selling 360,000 shares of Series B Non-Voting Convertible Preferred Stock at a conversion price of $1.36 per share, which can convert into 6,617,647 shares of common stock [2] - Each unit, consisting of a share of Preferred Stock and a warrant, is priced at $25.00, complying with Nasdaq's "Minimum Price" requirement [2] - The warrants are not exercisable until shareholder approval and will expire two and a half years after such approval [2][4] Group 2: Use of Proceeds - A portion of the net proceeds will be used to accelerate operational expansion at the Resource Group site in Myakka City, Florida, including purchasing additional processing equipment [5] - The company also plans to use proceeds for reducing debt obligations, strategic investments, acquisitions, and working capital to support revenue-generating operations [5] Group 3: Company Overview - Safe and Green Development Corporation focuses on real estate development and environmental solutions, primarily acquiring properties for green housing projects [7] - The company wholly owns Resource Group US Holdings LLC, which operates an 80+ acre organics processing facility in Florida, processing green waste and producing sustainable potting media [7]

Core Viewpoint - Ovid Therapeutics Inc. has announced a private investment in public equity (PIPE) financing expected to generate gross proceeds of up to $175 million, with an initial closing of approximately $81 million to support its operating plan and clinical pipeline through 2028 [1][6]. Financing Details - The PIPE financing is anticipated to close around October 6, 2025, pending customary closing conditions [1]. - New investors participating in the PIPE include Janus Henderson Investors, RA Capital Management, and others, alongside existing investors [2]. - The company is selling 57,722 shares of Series B non-voting convertible preferred stock, Series A warrants for 38,481,325 shares of common stock, and Series B warrants for 28,861,000 shares of common stock [3]. Securities Structure - Each share of Series B Preferred Stock is convertible into 1,000 shares of common stock, subject to stockholder approval and ownership limitations [4]. - Series A and Series B Warrants have an exercise price of $1.40 per share and will be exercisable following stockholder approval [5]. Use of Proceeds - The net proceeds from the PIPE financing will be used for research and development, general corporate expenses, and working capital needs, with expectations to fund operations into 2028 [6]. Company Overview - Ovid Therapeutics is focused on developing small molecule medicines for brain conditions with significant unmet needs, advancing a pipeline that includes OV329 for treatment-resistant seizures and other compounds targeting CNS disorders [10].

Core Viewpoint - Terra Innovatum Srl has secured $37.5 million in financing for its business combination with GSR III Acquisition Corp, which is expected to facilitate its entry into public markets and support the commercialization of its SOLO™ micro-modular reactor technology [1][2]. Financing Details - The financing includes approximately $32 million from a private investment in public equity (PIPE) led by Segra Capital Management and $5.5 million from a funded bridge facility that will convert to common equity upon closing [1][5]. - The PIPE investment is viewed as a strong endorsement of Terra Innovatum's technology and commercialization strategy [2]. Business Combination - An extraordinary general meeting of GSR III Acquisition Corp shareholders is scheduled for October 7, 2025, to approve the business combination with Terra Innovatum [2][3]. - If approved, the combined company will operate under the name Terra Innovatum and its shares are expected to trade on Nasdaq under the ticker symbol "NKLR" [5]. SOLO™ Micro-Modular Reactor - Terra Innovatum aims to make nuclear power accessible through its SOLO™ micro-modular reactor, which is designed to provide scalable, affordable, and deployable energy solutions [6][7]. - The SOLO™ reactor is engineered to address global energy shortages and is expected to be available globally within the next three years [8][9]. - It offers versatile applications, including CO2-free power solutions for various sectors such as data centers, remote towns, and industrial operations [10]. Strategic Goals - The proceeds from the financing will be utilized to support the licensing and construction of the SOLO™ reactor, furthering the company's mission to create lasting value for shareholders and communities [2][8]. - The reactor is designed to adapt to evolving fuel options and aims to replace fossil fuel-based thermal plants with a minimal footprint [9][10].

Core Viewpoint - Oruka Therapeutics has announced a PIPE financing agreement expected to generate approximately $180 million in gross proceeds to support its development of novel biologics for chronic skin diseases, particularly plaque psoriasis [1][3]. Financing Details - The PIPE financing involves the sale of 10,933,405 shares of common stock at $15.00 per share and pre-funded warrants for 1,066,666 shares at $14.999 each, with an exercise price of $0.001 per share [2]. - The transaction is anticipated to close around September 19, 2025, pending customary closing conditions [2]. Use of Proceeds - The net proceeds from the PIPE financing will be utilized for research and development, general corporate expenses, and working capital needs, with expectations that current cash will fund operations for at least one year following key clinical data readouts in 2027 [3]. Investor Participation - The PIPE financing was led by Viking Global Investors and included participation from various notable investors such as Affinity Healthcare Fund, Blackstone Multi-Asset Investing, and others [1][4]. Company Overview - Oruka Therapeutics focuses on developing biologics aimed at setting new treatment standards for chronic skin diseases, with a mission to provide significant relief to patients suffering from conditions like plaque psoriasis [7].

Core Insights - Kindly MD, a Bitcoin treasury company, is experiencing significant volatility, prompting CEO David Bailey to advise investors seeking short-term trades to exit [1] - The company recently submitted its S3 registration to the SEC, allowing shares from a $200 million PIPE deal to become freely tradable [1] - Following the registration, Kindly MD's shares dropped over 54%, reaching a low of $1.26, the lowest since February [2] Company Developments - Kindly MD completed its merger with Nakamoto Holdings, a Bitcoin-native holding company, making it a wholly owned subsidiary responsible for the Bitcoin financial services line [5] - Trading volume for Kindly MD has surged, with over 89 million shares traded, marking the highest volume since a rally in February [2][3] - The company has faced scrutiny regarding its stock price, as Nasdaq rules could impose warnings if shares close below $1 for 30 consecutive days [3]

Core Viewpoint - Forward Industries, Inc. successfully closed a private investment in public equity (PIPE) financing, raising approximately $1.65 billion in gross proceeds before expenses [1] Group 1 - The PIPE financing was led by notable investors including Galaxy Digital, Jump Crypto, and Multicoin Capital [1] - The funds raised will be utilized by Forward Industries for unspecified purposes, indicating potential growth or strategic initiatives [1]